---
title: Adragos Pharma vs Delpharm
slug_a: adragos-pharma
slug_b: delpharm
site: cdmo
review_signal_gate: closed
canonical_path: /compare/adragos-pharma/delpharm
generated_by: BioBM Editorial AI
---

# Adragos Pharma vs Delpharm

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Adragos Pharma (adragos-pharma) is listed for cdmo. Global CDMO headquartered in Munich offering end-to-end development and manufacturing for small molecules and biologics, including sterile/non-sterile liquids, solids, semi-solids, lyophilization, and prefilled syringes across seven facilities in Europe and Japan.

Services: 17. Modalities: 2. Indications: 1. Locations: 8. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (17).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Delpharm (delpharm) is listed for cdmo. Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually.

Services: 14. Modalities: 2. Indications: 0. Locations: 36. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (36).

Review summary: Review summary withheld until site-level review gate opens.